Faculty of Health, University of Technology Sydney, Ultimo, NSW, Australia.
Department of Rural Health, University of South Australia, Adelaide, SA, Australia.
J Asthma. 2021 Jul;58(7):865-873. doi: 10.1080/02770903.2020.1741609. Epub 2020 Mar 18.
This study aims to describe the prevalence of health care utilization (including conventional medicine, self-care and complementary medicine treatments) for the management of asthma by women aged 45 years and over and their associated out-of-pocket expenditure.
A self-reported mail survey of 375 Australian women, a cohort of the national 45 and Up Study, reporting a clinical diagnosis of asthma. The women were asked about their use of health care resources including conventional medicine, complementary medicine, and self-prescribed treatments for asthma and their associated out-of-pocket spending. Spearman's correlation coefficient, student's t-test and chi-square test were used as appropriate. Population level costs were created by extrapolating the costs reported by participants by available national prevalence data.
Survey respondents ( = 375; response rate, 46.9%) were, on average, 67.0 years old (min 53, max 91). The majority (69.1%; = 259) consulted at least one health care practitioner in the previous 12 months for their asthma. Most of the participants ( = 247; 65.9%) reported using at least one prescription medication for asthma in the previous 12 months. The total out-of-pocket expenditure on asthma treatment for Australian women aged 50 years and over is estimated to be AU$159 million per annum.
The breadth of conventional and complementary medicine health care services reported in this study, as well as the range of treatments that patients self-prescribe, highlights the challenges of coordinating care for individuals living with asthma.
本研究旨在描述 45 岁及以上女性患者为管理哮喘而使用(包括常规药物、自我护理和补充药物治疗)医疗保健的流行情况,以及其自付费用。
对澳大利亚全国性 45 岁以上研究的队列中 375 名有临床哮喘诊断的女性进行了一项自我报告的邮寄调查。这些女性被问及她们使用医疗保健资源的情况,包括常规药物、补充药物和自我开处方治疗哮喘及其自付费用。适当使用了 Spearman 相关系数、学生 t 检验和卡方检验。通过将参与者报告的成本外推到可用的全国流行数据,得出了人群水平的成本。
调查对象( = 375;回复率为 46.9%)的平均年龄为 67.0 岁(最小 53 岁,最大 91 岁)。大多数(69.1%; = 259)在过去 12 个月内因哮喘至少咨询过一位医疗保健从业者。大多数参与者( = 247;65.9%)在过去 12 个月内报告至少使用过一种处方药物治疗哮喘。估计澳大利亚 50 岁及以上女性治疗哮喘的自付费用总额为每年 1.59 亿澳元。
本研究报告了广泛的常规和补充药物医疗保健服务,以及患者自我开处方的一系列治疗方法,突出了协调患有哮喘的个人护理的挑战。